FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: Overseas Regulatory Announcement - Announcement regarding the first repurchase of A-shares through centralized bidding trade.
FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
FOSUN PHARMA: FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
FOSUN PHARMA: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
FOSUN PHARMA: Overseas Regulatory Announcement - Independent Non-Executive Director 2024 Annual Report (Yu Zishan)
FOSUN PHARMA: Overseas Regulatory Announcement - FOSUN PHARMA: Specific explanation regarding related party transactions involving Shanghai FOSUN PHARMA (Group) Co., Ltd.
FOSUN PHARMA: Overseas Regulatory Announcement - FOSUN PHARMA: Internal Control Audit Report for the Year 2024.
FOSUN PHARMA: Overseas regulatory announcement - Independent non-executive Director 2024 Annual Report (Wang Quandi)
FOSUN PHARMA: Overseas regulatory announcement - Regarding the risk continuous assessment report of Shanghai Fosun High Technology Group Financial Co., Ltd.
FOSUN PHARMA: Overseas regulatory announcement - FOSUN PHARMA: 2024 annual audit report.
FOSUN PHARMA: Overseas Regulatory Announcement - FOSUN PHARMA: Special explanation on non-operating fund occupation and Other related fund transactions for the year 2024.
FOSUN PHARMA: Overseas regulatory announcement - Independent non-executive Director 2024 annual report (Tang Gu Liang).
FOSUN PHARMA: Overseas Regulatory Announcement - Report from the Board of Directors Audit Committee on the supervision of the auditing firm for the annual audit of the year 2024.
FOSUN PHARMA: Overseas Regulatory Announcement - Independent Non-Executive Director 2024 Annual Work Report (Li Ling)
FOSUN PHARMA: Overseas Regulatory Announcement - FOSUN PHARMA: Verification Report on the Storage and Actual Use of Raised Funds for the Year 2024.
FOSUN PHARMA: Overseas Regulatory Announcement - Board of Directors Audit Committee 2024 Annual Performance Report
FOSUN PHARMA: Overseas regulatory announcement - Board of Directors' special opinion on the independence assessment of independent non-executive directors.
FOSUN PHARMA: Overseas Regulatory Announcement - Special Report on the Deposit and Actual Use of Funds Raised for the Year 2024.